Stocks TelegraphStocks Telegraph
Stock Ideas

FNCH Financial Statements and Analysis

NASDAQ : FNCH

Finch Therapeutics Group

$13.20
-0.05-0.38%
At Close 4:00 PM
63.43
BESG ScoreESG Rating

FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateJun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
revenue002.845M00
cost of revenue043.00K44.00K52.00K57.00K
gross profit0-43.00K2.801M-52.00K-57.00K
gross profit ratio000.98500
research and development expenses001.592M0203.00K
general and administrative expenses6.109M5.164M4.681M3.735M8.877M
selling and marketing expenses0-43.00K-44.00K00
selling general and administrative expenses6.109M5.121M4.637M3.735M8.877M
other expenses01.042M1.00M46.00K1.005M
operating expenses6.109M5.121M4.637M3.781M9.08M
cost and expenses6.109M5.164M4.681M3.781M9.08M
interest income0280.00K333.00K392.00K420.00K
interest expense0280.00K-98.024M392.00K420.00K
depreciation and amortization44.00K43.00K44.00K52.00K57.00K
ebitda-6.065M-5.121M-4.637M-3.781M-9.728M
ebitda ratio00-1.6300
operating income-6.109M-5.164M-4.681M-3.781M-9.881M
operating income ratio00-1.64500
total other income expenses net1.275M1.288M1.64M1.365M1.71M
income before tax-4.834M-3.876M-3.041M-2.416M-6.95M
income before tax ratio00-1.06900
income tax expense0-276.001.177M-52.00K-1.125M
net income-4.834M-3.876M-3.041M-2.416M-6.95M
net income ratio00-1.06900
eps-3.01-2.41-1.89-1.51-4.33
eps diluted-3.01-2.41-1.89-1.51-4.33
weighted average shs out1.606M1.606M1.606M1.605M1.605M
weighted average shs out dil1.606M1.606M1.606M1.605M1.605M
Graph

Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateJun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
cash and cash equivalents16.035M20.762M25.124M28.779M34.051M
short term investments00000
cash and short term investments16.035M20.762M25.124M28.779M34.051M
net receivables00000
inventory00000
other current assets1.244M413.00K723.00K1.14M2.448M
total current assets17.279M21.175M25.847M29.919M36.499M
property plant equipment net25.948M26.569M27.178M27.226M28.04M
goodwill00000
intangible assets00000
goodwill and intangible assets00-2.348M00
long term investments02.348M2.348M2.348M2.318M
tax assets0015.624M00
other non current assets2.349M-1.002.348M00
total non current assets28.297M28.917M45.15M29.574M30.358M
other assets01.00000
total assets45.576M50.092M70.997M59.493M66.857M
account payables29.00K47.00K141.00K357.00K432.00K
short term debt2.094M2.008M1.723M1.971M1.656M
tax payables00418.00K00
deferred revenue00-1.0000
other current liabilities2.339M1.444M2.22M2.551M7.487M
total current liabilities4.462M3.499M4.084M4.879M9.575M
long term debt26.895M27.555M28.403M28.801M29.388M
deferred revenue non current00-28.403M00
deferred tax liabilities non current0015.624M00
other non current liabilities0028.403M00
total non current liabilities26.895M27.555M44.027M28.801M29.388M
other liabilities001.0000
capital lease obligations28.989M27.555M28.403M30.772M31.044M
total liabilities31.357M31.054M48.111M33.68M38.963M
preferred stock00000
common stock2.00K2.00K2.00K2.00K2.00K
retained earnings-359.105M-354.271M-350.395M-347.354M-344.938M
accumulated other comprehensive income loss00000
other total stockholders equity373.322M373.307M373.279M373.165M372.83M
total stockholders equity14.219M19.038M22.886M25.813M27.894M
total equity14.219M19.038M22.886M25.813M27.894M
total liabilities and stockholders equity45.576M50.092M70.997M59.493M66.857M
minority interest00000
total investments02.348M2.348M2.348M2.318M
total debt28.989M29.563M30.126M30.772M31.044M
net debt12.954M8.801M5.002M1.993M-3.007M
Graph

Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateJun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202320232023
periodQ2Q1Q4Q3Q2
deferred income tax00-419.00K22.00K-797.00K
stock based compensation15.00K28.00K114.00K335.00K300.00K
change in working capital-528.00K-1.123M-786.00K-3.973M-3.564M
accounts receivables00-1.00K0107.00K
inventory00000
accounts payables-18.00K-94.00K-216.00K-76.00K-2.12M
other working capital-510.00K-1.029M-569.00K-3.897M-1.551M
other non cash items577.00K774.00K382.00K719.00K205.00K
net cash provided by operating activities-4.726M-4.362M-3.706M-5.261M-9.157M
investments in property plant and equipment0014.00K00
acquisitions net0037.00K20.00K1.27M
purchases of investments00000
sales maturities of investments00000
other investing activites00000
net cash used for investing activites0051.00K20.00K1.27M
debt repayment00-1.155M0-4.00K
common stock issued00000
common stock repurchased00000
dividends paid00000
other financing activites001.155M08.00K
net cash used provided by financing activities00004.00K
effect of forex changes on cash00001.00K
net change in cash-4.726M-4.362M-3.655M-5.242M-7.882M
cash at end of period18.384M20.762M25.124M31.127M36.369M
cash at beginning of period23.11M25.124M28.779M36.369M44.251M
operating cashflow-4.726M-4.362M-3.706M-5.261M-9.157M
capital expenditure0014.00K00
free cash flow-4.726M-4.362M-3.692M-5.261M-9.157M
Graph

Frequently Asked Questions

How did Finch Therapeutics Group, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, FNCH generated $0.00 in revenue last quarter, while its costs came in at $0.00.
Last quarter, how much Gross Profit did Finch Therapeutics Group, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Finch Therapeutics Group, Inc. reported a $0.00 Gross Profit for the quarter ended Jun 30, 2024.
Have FNCH's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. FNCH incurred $6.11M worth of Operating Expenses, while it generated -$6.11M worth of Operating Income.
How much Net Income has FNCH posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Finch Therapeutics Group, Inc., the company generated -$4.83M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Finch Therapeutics Group, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Finch Therapeutics Group, Inc. as of the end of the last quarter was $16.04M.
What are FNCH's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, FNCH had Total Net Receivables of $0.00.
In terms of Total Assets and Current Assets, where did Finch Therapeutics Group, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of FNCH were $17.28M, while the Total Assets stand at $45.58M.
As of the last quarter, how much Total Debt did Finch Therapeutics Group, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of FNCH's debt was $28.99M at the end of the last quarter.
What were FNCH's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, FNCH reported total liabilities of $31.36M.
How much did FNCH's Working Capital change over the last quarter?
Working Capital Change for FNCH was -$528.00K over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
FNCH generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. FNCH generated -$4.73M of Cash from Operating Activities during its recently reported quarter.
What was FNCH's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. FNCH reported a -$4.73M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph